Gründerfonds Ruhr is a private venture capital fund driving innovation in the Ruhr area by investing in new technologies impacting a broad range of industries. We deploy the capital, the business expertise and the industry access from leading international corporations who share our goal of building Ruhr-based start-ups with transforming ideas. Our objective is to be the institutional investor of choice for founders and become a trusted partner with the resources to catapult young companies to their next stage of development and commercial success. Our long-term vision is to thereby boost entrepreneurial spirit in our region. Key sectors include chemicals & new materials, energy & industrial sector, life sciences & healthcare, logistics & retail and the digital economy. Our current portfolio consists of Abalos Therapeutics, DIMATE, Emergence Therapeutics, Fasciotens, Masterplan.com and talpasolutions. For further information: www.gruenderfonds-ruhr.com